Development of a T cell receptor targeting an HLA-A*0201 restricted epitope from the cancer-testis antigen SSX2 for adoptive immunotherapy of cancer

Medicine & Life Sciences

• HLA-A*02:01 antigen 100%
• Synovial Sarcoma 88%
• Adoptive Immunotherapy 86%
• Testicular Neoplasms 74%
• T-Cell Antigen Receptor 66%
• Epitopes 56%
• Antigens 41%
• Neoplasms 21%
• Lymphocytes 17%
• Melanoma 13%
• T-Cell Antigen Receptor Specificity 11%
• HLA-A2 Antigen 11%
• T-Cell Receptor Genes 10%
• T-Lymphocytes 10%
• Tumor Cell Line 8%
• Multiple Myeloma 8%
• Codon 8%
• Pancreatic Neoplasms 7%
• Genetic Therapy 7%
• Interferons 7%
• Organism Cloning 7%
• Immunotherapy 7%
• Lymphoma 6%
• Clone Cells 6%
• Prostatic Neoplasms 6%
• Histology 6%
• Lymph Nodes 5%
• Peptides 5%
• Genes 3%

Agriculture & Biology

• immunotherapy 87%
• sarcoma 78%
• epitopes 63%
• T-lymphocytes 59%
• testes 54%
• neoplasms 50%
• antigens 49%
• receptors 44%
• melanoma 12%
• lymphocytes 9%
• pancreatic neoplasms 8%
• retroviral vectors 8%
• gene therapy 7%
• prostatic neoplasms 7%
• myeloma 6%
• lymphoma 6%
• blood 6%
• lymphocyte proliferation 6%
• interferons 6%
• lymph nodes 5%
• histology 5%
• codons 5%
• cells 5%
• tissues 4%
• germ cells 4%
• molecular cloning 4%
• cell lines 4%
• peptides 3%
• clones 3%
• genes 1%

Chemical Compounds

• Epitope 66%
• Antigen 54%
• Tetramer 43%